Sun Pharma has a robust pipeline in specialty business which will drive its profitability and free cash flow in the near future
January 13, 2017
After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?
Krishna Gopalan - January 22, 2016
New-age digital bankers
A mix of players are looking to give traditional banks a run for their money as payment banking comes of age
Kripa Mahalingam - July 28, 2015
The Sun Pharma founder is a man of few words and the perfect dose of calm and strength
Krishna Gopalan - July 02, 2015
Dilip Shanghvi holding on to what he has created even as his peers cash out shows his confidence in the business
N Mahalakshmi - April 29, 2015
Wind beneath his wings
India's most reticent billionaire is betting his money on the alternative energy space and here's why
Krishna Gopalan - May 05, 2015
Will Sun rise again?
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
Kripa Mahalingam - June 15, 2015